Elizabeth Lamping
- Co-authors
- James L. GulleyJeffrey SchlomRavi A. MadanJennifer L. MartéRenee N. DonahueChristopher R. HeeryLisa M. CordesJulius Strauss
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Cancer Research and Treatments (4 papers)Colorectal Cancer Treatments and Studies (4 papers)
- Cited by
- OncologyImmunologyBiotechnology
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Elizabeth Lamping
20 papers receiving 849 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Oncology 694
- Immunology 354
- Molecular Biology 153
- Surgery 139
- Pulmonary and Respiratory Medicine 139
Countries citing papers authored by Elizabeth Lamping
This map shows the geographic impact of Elizabeth Lamping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Lamping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Lamping more than expected).
Fields of papers citing papers by Elizabeth Lamping
This network shows the impact of papers produced by Elizabeth Lamping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Lamping. The network helps show where Elizabeth Lamping may publish in the future.
Co-authorship network of co-authors of Elizabeth Lamping
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Lamping. A scholar is included among the top collaborators of Elizabeth Lamping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Lamping. Elizabeth Lamping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 9 | |
| 5 | 3 | |
| 6 | 8 | |
| 7 | 4 | |
| 8 | 10 | |
| 9 | 5 | |
| 10 | 17 | |
| 11 | 1 | |
| 12 | 45 | |
| 13 | 15 | |
| 14 | 116 | |
| 15 | Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumorsbreakdown → | 327 |
| 16 | 19 | |
| 17 | 230 | |
| 18 | 17 | |
| 19 | 2 | |
| 20 | 11 |
About Elizabeth Lamping
Elizabeth Lamping is a scholar working on Biotechnology, Oncology and Immunology, having authored 20 papers that have together received 859 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (694 citations), Immunology (354 citations) and Biotechnology (41 citations). Elizabeth Lamping has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include James L. Gulley, Jeffrey Schlom, Ravi A. Madan, Jennifer L. Marté, Renee N. Donahue, Christopher R. Heery, Lisa M. Cordes, Julius Strauss, Italia Grenga and Christoph Helwig. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.